469 related articles for article (PubMed ID: 32166165)
1. Purine and purinergic receptors.
Burnstock G
Brain Neurosci Adv; 2018; 2():2398212818817494. PubMed ID: 32166165
[TBL] [Abstract][Full Text] [Related]
2. Purine and pyrimidine receptors.
Burnstock G
Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
[TBL] [Abstract][Full Text] [Related]
3. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
4. Purinergic signaling: Diverse effects and therapeutic potential in cancer.
Kaur J; Dora S
Front Oncol; 2023; 13():1058371. PubMed ID: 36741002
[TBL] [Abstract][Full Text] [Related]
5. Purinergic Signalling: Therapeutic Developments.
Burnstock G
Front Pharmacol; 2017; 8():661. PubMed ID: 28993732
[TBL] [Abstract][Full Text] [Related]
6. Purinoceptors: are there families of P2X and P2Y purinoceptors?
Abbracchio MP; Burnstock G
Pharmacol Ther; 1994; 64(3):445-75. PubMed ID: 7724657
[TBL] [Abstract][Full Text] [Related]
7. The P2Y/P2X divide: How it began.
Kennedy C
Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
[TBL] [Abstract][Full Text] [Related]
8. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.
Woods LT; Forti KM; Shanbhag VC; Camden JM; Weisman GA
Biochem Pharmacol; 2021 May; 187():114406. PubMed ID: 33412103
[TBL] [Abstract][Full Text] [Related]
9. Introductory overview of purinergic signalling.
Burnstock G
Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
[TBL] [Abstract][Full Text] [Related]
10. That was then, this is now: the development of our knowledge and understanding of P2 receptor subtypes.
Kennedy C
Purinergic Signal; 2021 Mar; 17(1):9-23. PubMed ID: 33527235
[TBL] [Abstract][Full Text] [Related]
11. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
12. Blood cells: an historical account of the roles of purinergic signalling.
Burnstock G
Purinergic Signal; 2015 Dec; 11(4):411-34. PubMed ID: 26260710
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
14. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
Yu Y; Zhang C
Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
16. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
[TBL] [Abstract][Full Text] [Related]
17. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
18. Purinergic transmission in blood vessels.
Ralevic V; Dunn WR
Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide receptors.
North RA; Barnard EA
Curr Opin Neurobiol; 1997 Jun; 7(3):346-57. PubMed ID: 9232809
[TBL] [Abstract][Full Text] [Related]
20. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
